Wealth Manager - the site for professional investment managers

Register to get unlimited access to all of Citywire’s Fund Manager database. Registration is free and only takes a minute.

Woodford backs Astra rebuff of Pfizer's 'final offer'

Woodford backs Astra rebuff of Pfizer's 'final offer'

Leading fund manager Neil Woodford has warned that politicians should leave the fate of corporate takeover bids to boards and shareholders, as AstraZeneca rejected Pfizer's 'final offer'.

Woodford told Sky News that he is supportive of AstraZeneca's rejection of Pfizer's £69.3 billion bid, particularly as an investor in early-stage medical research businesses. However, he warned the UK should not take a protectionist stance towards takeovers.

'It is right that the market decides,' Woodford said.

'I share the concerns about critical infrastructure of the UK's science base and jobs, because I have been an investor in early-stage medical research businesses and know that the loss of key jobs can be damaging.

'Politicians should not be deciding these things. A free market in corporate control is appropriate, because boards and shareholders should decide the destiny of the ownership of companies.'

On Monday, AstraZeneca's shares fell more than 11% to £42.81 on the news that Astra would not accept a £55 per share offer from Pfizer.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Navigating geopolitical risk with ETFs

Navigating geopolitical risk with ETFs

ETFGI’s Deborah Fuhr on how investors can use exchange-traded funds to position their portfolio.

Play Sarasin’s Boucher: why I like salmon with chocolate

Sarasin’s Boucher: why I like salmon with chocolate

Henry Boucher, manager of the £129 million Sarasin Food & Agriculture Opportunities fund, explains why he is gobbling up salmon and chocolate stocks.

Play Alibaba hype, the UK slowdown and opportunities in European sovereign bonds

Alibaba hype, the UK slowdown and opportunities in European sovereign bonds

Libby Ashby and leading wealth managers analyse what the Alibaba IPO hype means for Chinese equities, slowing growth of the UK economy and whether there’s anything left to play for in the European sovereign bond market.

Your Business: Cover Star Club

Profile: How David Esfandi is shaping Canaccord Genuity WM

Profile: How David Esfandi is shaping Canaccord Genuity WM

After six months as chief executive of Canaccord Genuity David Esfandi's ambitions are taking shape

Wealth Manager on Twitter